0.2887
price down icon11.25%   -0.0366
pre-market  Pre-market:  .29   0.0013   +0.45%
loading
Sensei Biotherapeutics Inc stock is traded at $0.2887, with a volume of 543.84K. It is down -11.25% in the last 24 hours and down -34.01% over the past month.
See More
Previous Close:
$0.3253
Open:
$0.3095
24h Volume:
543.84K
Relative Volume:
0.20
Market Cap:
$7.26M
Revenue:
-
Net Income/Loss:
$-29.80M
P/E Ratio:
-0.2426
EPS:
-1.19
Net Cash Flow:
$-25.19M
1W Performance:
-43.20%
1M Performance:
-34.01%
6M Performance:
-42.27%
1Y Performance:
-70.84%
1-Day Range:
Value
$0.2887
$0.3443
1-Week Range:
Value
$0.25
$0.4998
52-Week Range:
Value
$0.25
$1.94

Sensei Biotherapeutics Inc Stock (SNSE) Company Profile

Name
Name
Sensei Biotherapeutics Inc
Name
Phone
(240) 243-8000
Name
Address
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
2025-03-28
Name
Latest SEC Filings
Name
SNSE's Discussions on Twitter

Compare SNSE with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
SNSE
Sensei Biotherapeutics Inc
0.2887 7.26M 0 -29.80M -25.19M -1.19
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Sensei Biotherapeutics Inc Stock (SNSE) Upgrades & Downgrades

Date Action Analyst Rating Change
May-14-24 Initiated Stephens Overweight
Jul-01-21 Downgrade Berenberg Buy → Hold
Jun-29-21 Downgrade Oppenheimer Outperform → Perform
Mar-01-21 Initiated Berenberg Buy
Mar-01-21 Initiated Citigroup Buy
Mar-01-21 Initiated Oppenheimer Outperform
Mar-01-21 Initiated Piper Sandler Overweight
View All

Sensei Biotherapeutics Inc Stock (SNSE) Latest News

pulisher
Apr 03, 2025

Penny Stocks To Add to Your WatchlistMarch 30th - MarketBeat

Apr 03, 2025
pulisher
Apr 02, 2025

Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference - The Manila Times

Apr 02, 2025
pulisher
Apr 02, 2025

Promising Penny Stocks To ResearchMarch 29th - MarketBeat

Apr 02, 2025
pulisher
Apr 02, 2025

Best Penny Stocks To Follow NowMarch 28th - MarketBeat

Apr 02, 2025
pulisher
Mar 31, 2025

Sensei Biotherapeutics stock hits 52-week low at $0.34 By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Sensei Biotherapeutics stock hits 52-week low at $0.34 - Investing.com

Mar 31, 2025
pulisher
Mar 30, 2025

HC Wainwright Reiterates Buy Rating for Sensei Biotherapeutics (NASDAQ:SNSE) - Defense World

Mar 30, 2025
pulisher
Mar 30, 2025

Sensei Biotherapeutics (NASDAQ:SNSE) Price Target Raised to $4.00 at Oppenheimer - Armenian Reporter

Mar 30, 2025
pulisher
Mar 30, 2025

Sensei Biotherapeutics (NASDAQ:SNSE) Stock Price Expected to Rise, Oppenheimer Analyst Says - Defense World

Mar 30, 2025
pulisher
Mar 29, 2025

Sensei Biotherapeutics Reports Promising 2024 Results - TipRanks

Mar 29, 2025
pulisher
Mar 28, 2025

Sensei Biotherapeutics (SNSE) Reports Annual Loss and Decline in Cash Reserves - GuruFocus

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei stock holds Buy rating, $4 target from H.C. Wainwright By Investing.com - Investing.com Australia

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei Rockets on FY ’24 Results - Baystreet.ca

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei Biotherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 - Marketscreener.com

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei Biotherapeutics Reports Favorable Initial Clinical Activity Data For Solnerstotug In Resistant Tumors - Benzinga

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei Biotherapeutics price target raised to $4 from $3.50 at Oppenheimer - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Oppenheimer Adjusts Price Target on Sensei Biotherapeutics to $4 From $3.50, Maintains Outperform Rating - Marketscreener.com

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei stock holds Buy rating, $4 target from H.C. Wainwright - Investing.com India

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei Biotherapeutics reports FY24 EPS ($1.20) vs ($1.22) last year - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei Biotherapeutics Inc Cash Runway Into Q2 Of 2026 - MarketScreener

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei Biotherapeutics, Inc. SEC 10-K Report - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei Biotherapeutics Reports Full Year 2024 Financial Results and Update on Clinical Progress - GlobeNewswire

Mar 28, 2025
pulisher
Mar 28, 2025

Breakthrough: Sensei's Cancer Drug Triples Response Rate in Hard-to-Treat Tumors - Stock Titan

Mar 28, 2025
pulisher
Mar 27, 2025

Sensei Biotherapeutics announces initial results from solnerstotug trial portion - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data For Solnerstotug In PD-(L)1 Resistant Tumors - Marketscreener.com

Mar 27, 2025
pulisher
Mar 27, 2025

Sensei Biotherapeutics : Company Presentation March 2025 - Marketscreener.com

Mar 27, 2025
pulisher
Mar 27, 2025

Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors - GlobeNewswire

Mar 27, 2025
pulisher
Mar 27, 2025

Revolutionary Cancer Treatment Triples Response Rate in Hard-to-Treat Tumors: Clinical Trial Results Revealed - Stock Titan

Mar 27, 2025
pulisher
Mar 21, 2025

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) Sees Large Drop in Short Interest - Defense World

Mar 21, 2025
pulisher
Mar 07, 2025

Sensei Biotherapeutics Stock Price, Quotes and Forecasts | NASDAQ:SNSE - Benzinga

Mar 07, 2025
pulisher
Feb 24, 2025

Sensei Biotherapeutics Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView

Feb 24, 2025
pulisher
Feb 19, 2025

Sensei Biotherapeutics (SNSE) to Release Quarterly Earnings on Wednesday - Defense World

Feb 19, 2025
pulisher
Feb 07, 2025

What Makes Sensei Biotherapeutics (SNSE) a New Buy Stock - MSN

Feb 07, 2025
pulisher
Feb 06, 2025

A stock that deserves closer examination: Sensei Biotherapeutics Inc (SNSE) - US Post News

Feb 06, 2025
pulisher
Feb 04, 2025

Sensei Biotherapeutics to Participate in Oppenheimer’s 35th Annual Healthcare Life Sciences Conference - GlobeNewswire

Feb 04, 2025
pulisher
Feb 04, 2025

Sensei Biotherapeutics to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference - The Manila Times

Feb 04, 2025
pulisher
Feb 04, 2025

Biotech Spotlight: Sensei Bio Takes Center Stage at Major Healthcare Conference - StockTitan

Feb 04, 2025
pulisher
Jan 27, 2025

Sensei Biotherapeutics, Inc. Appoints Robert Pierce as Chief Scientific Officer; Opens its Boston Office - Marketscreener.com

Jan 27, 2025
pulisher
Jan 11, 2025

Sensei Biotherapeutics Inc Shares Rise 25.49% From The Lows – But Will They Continue? - Marketing Sentinel

Jan 11, 2025
pulisher
Jan 10, 2025

Biotech Advances Breakthrough Cancer Treatment Results - Streetwise Reports

Jan 10, 2025
pulisher
Jan 10, 2025

Sensei Biotherapeutics (NASDAQ:SNSE) Earns Buy Rating from HC Wainwright - Defense World

Jan 10, 2025
pulisher
Jan 08, 2025

Sensei Biotherapeutics faces Nasdaq delisting risk By Investing.com - Investing.com Australia

Jan 08, 2025
pulisher
Jan 08, 2025

Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones - The Manila Times

Jan 08, 2025
pulisher
Jan 08, 2025

Sensei Bio's Cancer Drug Shows Promise in Phase 1/2 Trial, Enrolls 45 Patients for VISTA Study - StockTitan

Jan 08, 2025
pulisher
Jan 08, 2025

Sensei Biotherapeutics faces Nasdaq delisting risk - Investing.com

Jan 08, 2025
pulisher
Nov 27, 2024

Sensei Biotherapeutics to Participate in Citi’s 2024 Global Healthcare Conference - GlobeNewswire

Nov 27, 2024
pulisher
Nov 18, 2024

Sensei Biotherapeutics Q3 2024 Results and Strategic Moves - TipRanks

Nov 18, 2024
pulisher
Nov 15, 2024

Layoff Tracker: Sensei to Cut 46% of Workforce, Close Research Site - BioSpace

Nov 15, 2024
pulisher
Nov 14, 2024

Sensei Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

Sensei Biotherapeutics Inc. (SNSE) Quarterly 10-Q Report - Quartzy

Nov 14, 2024

Sensei Biotherapeutics Inc Stock (SNSE) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Cap:     |  Volume (24h):